Publications by authors named "E Diral"

Claim this Profile
S
Safety and effectiveness of the combination of 5-azacitidine and ruxolitinib in VEXAS syndrome: A single-centre experience.
Gregorio Maria Bergonzi, Enrico Cozzo, Alessandro Tomelleri, Costanza Piccolo, Gianluca Scorpio, Elisa Diral

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome.
Edoardo Campodonico, Piera Angelillo, Matteo Doglio, Alessia Ugolini, Maria Teresa Lupo Stanghellini, Elisa Diral

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of letermovir on Cytomegalovirus-specific T-cells reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era.
Elena Tassi, Giorgio Orofino, Valeria Beretta, Veronica Valtolina, Gregorio Maria Bergonzi, Elisa Diral

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study.
Tali Eviatar, Dafne Capelusnik, Corrado Campochiaro, Valentin Lacombe, Vincent Jachiet, Elisa Diral

Arthritis Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.
Arsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, Sinisa Savic, Matthew J Koster, Elisa Diral

Arthritis Rheumatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis